163 related articles for article (PubMed ID: 36121803)
1. Activity monitoring and patient-reported outcome measures in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome patients.
Rekeland IG; Sørland K; Bruland O; Risa K; Alme K; Dahl O; Tronstad KJ; Mella O; Fluge Ø
PLoS One; 2022; 17(9):e0274472. PubMed ID: 36121803
[TBL] [Abstract][Full Text] [Related]
2. The utility of patient-reported outcome measures among patients with myalgic encephalomyelitis/chronic fatigue syndrome.
Murdock KW; Wang XS; Shi Q; Cleeland CS; Fagundes CP; Vernon SD
Qual Life Res; 2017 Apr; 26(4):913-921. PubMed ID: 27600520
[TBL] [Abstract][Full Text] [Related]
3. Validation of the Severity of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome by Other Measures than History: Activity Bracelet, Cardiopulmonary Exercise Testing and a Validated Activity Questionnaire: SF-36.
van Campen CLMC; Rowe PC; Visser FC
Healthcare (Basel); 2020 Aug; 8(3):. PubMed ID: 32823979
[TBL] [Abstract][Full Text] [Related]
4. Medical Care Situation of People with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in Germany.
Froehlich L; Hattesohl DBR; Jason LA; Scheibenbogen C; Behrends U; Thoma M
Medicina (Kaunas); 2021 Jun; 57(7):. PubMed ID: 34201825
[No Abstract] [Full Text] [Related]
5. Intravenous Cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. An Open-Label Phase II Study.
Rekeland IG; Fosså A; Lande A; Ktoridou-Valen I; Sørland K; Holsen M; Tronstad KJ; Risa K; Alme K; Viken MK; Lie BA; Dahl O; Mella O; Fluge Ø
Front Med (Lausanne); 2020; 7():162. PubMed ID: 32411717
[No Abstract] [Full Text] [Related]
6. Physical activity measures in patients with myalgic encephalomyelitis/chronic fatigue syndrome: correlations between peak oxygen consumption, the physical functioning scale of the SF-36 questionnaire, and the number of steps from an activity meter.
van Campen CMC; Rowe PC; Verheugt FWA; Visser FC
J Transl Med; 2020 Jun; 18(1):228. PubMed ID: 32513266
[TBL] [Abstract][Full Text] [Related]
7. Health outcomes of sensory hypersensitivities in myalgic encephalomyelitis/chronic fatigue syndrome and multiple sclerosis.
Maeda KI; Islam MF; Conroy KE; Jason L
Psychol Health Med; 2023 Dec; 28(10):3052-3063. PubMed ID: 36977713
[TBL] [Abstract][Full Text] [Related]
8. Reduced heart rate variability predicts fatigue severity in individuals with chronic fatigue syndrome/myalgic encephalomyelitis.
Escorihuela RM; Capdevila L; Castro JR; Zaragozà MC; Maurel S; Alegre J; Castro-Marrero J
J Transl Med; 2020 Jan; 18(1):4. PubMed ID: 31906988
[TBL] [Abstract][Full Text] [Related]
9. Psychometric evaluation of the DePaul Symptom Questionnaire-Short Form (DSQ-SF) among adults with Long COVID, ME/CFS, and healthy controls: A machine learning approach.
McGarrigle WJ; Furst J; Jason LA
J Health Psychol; 2024 Jan; ():13591053231223882. PubMed ID: 38282368
[TBL] [Abstract][Full Text] [Related]
10. The development of a short form of the DePaul Symptom Questionnaire.
Sunnquist M; Lazarus S; Jason LA
Rehabil Psychol; 2019 Nov; 64(4):453-462. PubMed ID: 31318234
[TBL] [Abstract][Full Text] [Related]
11. Assessing severity of illness and outcomes of treatment in children with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME): a systematic review of patient-reported outcome measures (PROMs).
Haywood KL; Collin SM; Crawley E
Child Care Health Dev; 2014 Nov; 40(6):806-24. PubMed ID: 24661148
[TBL] [Abstract][Full Text] [Related]
12. Defining the prevalence and symptom burden of those with self-reported severe chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME): a two-phase community pilot study in the North East of England.
Strassheim VJ; Sunnquist M; Jason LA; Newton JL
BMJ Open; 2018 Sep; 8(9):e020775. PubMed ID: 30232103
[TBL] [Abstract][Full Text] [Related]
13. Psychometric properties of the PROMIS
Yang M; Keller S; Lin JS
Qual Life Res; 2019 Dec; 28(12):3375-3384. PubMed ID: 31506915
[TBL] [Abstract][Full Text] [Related]
14. Exploring Symptom Fluctuations and Triggers in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Using Novel Patient-Centred N-of-1 Observational Designs: A Protocol for a Feasibility and Acceptability Study.
McDonald S; Tan SX; Banu S; van Driel M; McGree JM; Mitchell G; Nikles J
Patient; 2022 Mar; 15(2):197-206. PubMed ID: 34368926
[TBL] [Abstract][Full Text] [Related]
15. Graded exercise therapy compared to activity management for paediatric chronic fatigue syndrome/myalgic encephalomyelitis: pragmatic randomized controlled trial.
Gaunt DM; Brigden A; Harris SRS; Hollingworth W; Jago R; Solomon-Moore E; Beasant L; Mills N; Sinai P; Crawley E; Metcalfe C
Eur J Pediatr; 2024 May; 183(5):2343-2351. PubMed ID: 38429546
[TBL] [Abstract][Full Text] [Related]
16. Defining the minimally clinically important difference of the SF-36 physical function subscale for paediatric CFS/ME: triangulation using three different methods.
Brigden A; Parslow RM; Gaunt D; Collin SM; Jones A; Crawley E
Health Qual Life Outcomes; 2018 Oct; 16(1):202. PubMed ID: 30340599
[TBL] [Abstract][Full Text] [Related]
17. Faecal microbiota transplantation (FMT) in Norwegian outpatients with mild to severe myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): protocol for a 12-month randomised double-blind placebo-controlled trial.
Skjevling L; Goll R; Hanssen HM; Johnsen PH
BMJ Open; 2024 Jun; 14(6):e073275. PubMed ID: 38858151
[TBL] [Abstract][Full Text] [Related]
18. Cognitive behavioural therapy in chronic fatigue syndrome: a randomised controlled trial of an outpatient group programme.
O'Dowd H; Gladwell P; Rogers CA; Hollinghurst S; Gregory A
Health Technol Assess; 2006 Oct; 10(37):iii-iv, ix-x, 1-121. PubMed ID: 17014748
[TBL] [Abstract][Full Text] [Related]
19. Test-Retest Reliability of the DePaul Symptom Questionnaire.
Jason LA; So S; Brown AA; Sunnquist M; Evans M
Fatigue; 2015 Jan; 3(1):16-32. PubMed ID: 26973799
[TBL] [Abstract][Full Text] [Related]
20. Pain is associated with reduced quality of life and functional status in patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Strand EB; Mengshoel AM; Sandvik L; Helland IB; Abraham S; Nes LS
Scand J Pain; 2019 Jan; 19(1):61-72. PubMed ID: 30325738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
